U.S. flag An official website of the United States government
  1. Home
  2. Drugs
  3. Drug Safety and Availability
  4. FDA requests the withdrawal of the weight-loss drug Belviq, Belviq XR (lorcaserin) from the market
  1. Drug Safety and Availability

FDA requests the withdrawal of the weight-loss drug Belviq, Belviq XR (lorcaserin) from the market

Potential risk of cancer outweighs the benefits

2-13-2020  FDA Drug Safety Communication

Drug Safety Communication (PDF - 62KB)

Related Information

Contact FDA

For More Info
855-543-DRUG (3784) and press 4
druginfo@fda.hhs.gov

Report a Serious Problem to MedWatch
Complete and submit the report Online.
Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178.